中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Wenxuan YIN)

1.Research progress of role of SOCS-3 in treating liver fibrosis

Zili ZHANG ; Shifeng ZHAO ; Wenxuan XU ; Feng ZHANG ; Li WU ; Yin LU ; Shizhong ZHENG

Chinese Pharmacological Bulletin 2015;(12):1646-1651

2.Progress on roles and mechanisms of farnesoid X receptor (FXR) in chronic liver diseases

Wenxuan XU ; Zili ZHANG ; Shifeng ZHAO ; Feng ZHANG ; Li WU ; Yin LU ; Shizhong ZHENG

Chinese Pharmacological Bulletin 2016;32(3):314-318,319

3.ERp44 C160S/C212S mutants regulate IP3R1 channel activity.

Congyan PAN ; Ji ZHENG ; Yanyun WU ; Yingxiao CHEN ; Likun WANG ; Zhansong ZHOU ; Wenxuan YIN ; Guangju JI

Protein & Cell 2011;2(12):990-996

4.Mediating role of health education competency in the relationship between supportive communication and general self-efficacy among medical undergraduates

Hui YIN ; Wenxuan LI ; Ying ZHANG ; Yuchun TAO ; Zehui LI ; Wei LIU ; Zuoming ZHANG ; Limin WANG ; Depin CAO

Chinese Journal of Medical Education Research 2024;23(3):347-352

5.The strategy and feasibility of dose optimization in clinical target volume Ⅱb in patients with N 0-N 1 nasopharyngeal carcinoma

Wenxuan HUANG ; Dan ZONG ; Bin ZHANG ; Lijun WANG ; Lanfan ZHANG ; Chengxian MA ; Li YIN ; Shengfu HUANG ; Xia HE

Chinese Journal of Radiation Oncology 2022;31(9):778-784

6.Enlightenment of Prevention Experience of Scientific Misconduct in Extraterritorial Medical Field to China

Shichao WANG ; Mei YIN ; Wenxuan XU ; Hong ZHU

Chinese Medical Ethics 2022;35(6):619-624

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO